CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

AKTSAktis Oncology, Inc.

Last close $19.47 · 2026-09-30
RECENT INSIDER TRADES
  • 2026-09-24 · Czibere Akos (Chief Medical Officer) · SELL
  • 2026-09-24 · Czibere Akos (Chief Medical Officer) · OTHER
  • 2026-07-21 · Herrmann Ken (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders115
Shares held35,624,204
Value$1.04B
As of quarter end2026-06-30
RECENT NEWS
  • Aktis Oncology initiates phase 1b trial for lung cancer drug
  • Aktis Oncology presents at Morgan Stanley healthcare conference
  • Aktis Oncology discusses platform bets and capital strength at Morgan Stanley conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Aktis Oncology, Inc. (AKTS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit